Do you know which molecular markers signify poor-risk disease in AML? And how about what makes AML a challenging disease to manage in older adult patients? Test your knowledge in our latest quiz.
Know when to change targeted therapies in patients with progressive lung cancer? How about appropriate patient criteria for segmentectomy or wedge resection? Test your knowledge in our latest quiz.
Which somatic mutation do most high-grade serous ovarian carcinomas harbor? And what percentage of endometrioid endometrial tumors have copy-number alterations? Test your knowledge in our latest quiz.
Is the use of bisphosphonates in patients with multiple myeloma associated with improved progression-free or overall survival? Is hypertension a risk factor for carfilzomib-related cardiopulmonary toxicities? Test your knowledge in our latest quiz.
Which genetic mutation confers shorter progression-free survival in myelofibrosis patients undergoing allogeneic stem cell transplantation? And what is the only potentially curative treatment for primary myelofibrosis? Test your knowledge in our latest quiz.
In patients with stage IIIA non–small-cell lung cancer, should the presence of N2 disease be determined by both radiologic and invasive staging prior to treatment initiation? Are ALK rearrangements and EGFR mutations mutually exclusive? Test your knowledge in our latest quiz.
Do you know which factors predict poor prognosis in patients with neuroendocrine tumors? How about the estimated number of patients who will be diagnosed with neuroendocrine tumors this year in the United States? Test your knowledge in our latest quiz.
What are secondary adjuvant therapy options for stages II–IV ovarian cancer patients in complete remission? And do you know if fertility preservation is possible in patients with stage I ovarian cancer? Test your knowledge on these topics and more in our latest quiz.
What single agent does the new ASCO guideline recommend for first-line treatment of patients with stage IV non-small-cell lung cancer without positive markers but with high PD-L1 expression? Is there an age limit for use of SBRT for early-stage lung cancer? Test your knowledge in our latest quiz.
What is the real-world economic burden associated with complications from hematopoietic cell transplantation? What prognostic factors for posttransplantation outcomes among patients with chronic myelomonocytic leukemia are significant predictors of survival? Answer these and more in our latest quiz.